U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07750990) titled 'An Extension Study of S-606001 in Participants With Late-onset Pompe Disease (LOPD)' on July 30.
Brief Summary: The primary purpose of this study is to evaluate the long-term safety and tolerability profile of S-606001 in participants with LOPD.
Participants who completed other S-606001 studies (for example, NCT07123155), including participants in a S-606001 study whose allocated arm was terminated by the sponsor and who are willing to participate in this study, will be enrolled globally.
Study Start Date: Aug. 31
Study Type: INTERVENTIONAL
Condition:
Pompe Disease
Intervention:
DRUG: S-606001
S-606001 will be administered or...